Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–Drug–Gene Interactions in Cardiovascular Medicine
Innocent G. Asiimwe, Munir Pirmohamed
Pharmacogenomics and Personalized Medicine (2022) Vol. Volume 15, pp. 879-911
Open Access | Times Cited: 12

Showing 12 citing articles:

Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population
Ambily Sivadas, Soumitra Sahana, Bani Jolly, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 2, pp. e003769-e003769
Open Access | Times Cited: 6
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
Anna Bollinger, Melissa Semedo Fortes, Henriette E. Meyer zu Schwabedissen, et al.
Pharmacy (2025) Vol. 13, Iss. 1, pp. 14-14
Open Access
System Overview from Physiological and Pathological Standpoints
Gustavo Rodrigues Pedrino, Luíza Toubas Chaul, Virgínia Farias Alves, et al.
(2025), pp. 1-34
Closed Access
Tổng quan về các tương tác thuốc có ý nghĩa lâm sàng thường gặp trên bệnh nhân tim mạch
Phan Nguyễn Thu Xuân Phan Nguyễn Thu Xuân, Võ Phát Đạt Vo Phat Dat, Trần Phú Điền Tran Phu Dien, et al.
TẠP CHÍ KHOA HỌC TRƯỜNG ĐẠI HỌC QUỐC TẾ HỒNG BÀNG (2025)
Closed Access
In vivo effects of bempedoic acid on microdosed CYP probe drugs
Felicitas Stoll, Salvatore Amato, Jürgen Burhenne, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism
Jing Wang, Yingying Hu, Qingqing Li, et al.
Chemico-Biological Interactions (2024) Vol. 392, pp. 110924-110924
Closed Access | Times Cited: 4
Genetics in Ischemic Stroke: Current Perspectives and Future Directions
Ka Zhang, Shaun Seh Ern Loong, Linus ZH Yuen, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 12, pp. 495-495
Open Access | Times Cited: 7
Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes
Abdelrahman Saqr, Mahmoud Al‐Kofahi, Moataz E. Mohamed, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 11, pp. 2837-2848
Open Access | Times Cited: 1
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
Anna Bollinger, Céline K. Stäuble, Chiara Jeiziner, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 693-706
Open Access | Times Cited: 3
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, et al.
Genes (2023) Vol. 14, Iss. 11, pp. 2057-2057
Open Access | Times Cited: 2
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions
Laura Russell, Katrina G. Claw, Kaja M. Aagaard, et al.
Drug Metabolism Reviews (2024), pp. 1-19
Closed Access
Implementing population pharmacogenomics: Tailoring drug therapy for diverse populations
Kariofyllis Karamperis, George P. Patrinos
Elsevier eBooks (2024), pp. 143-158
Closed Access
The Implementation of Personalized Medicine in the Republic of Moldova: Challenges and Opportunities in Cardiology
Alexei Leviţchi, Daniela Galea-Abduşa, Victor Sontea, et al.
IFMBE proceedings (2023), pp. 288-298
Closed Access
Page 1

Scroll to top